Rituximab plus methotrexate-based chemotherapy (R-MPV) and whole-brain radiotherapy (WBRT) is promising for primary CNS lymphoma

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1613, 2007-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy for Primary CNS Lymphoma: Progress Beyond Methotrexate?

By Graber Jerome J.   Omuro Antonio  

CNS Drugs, Vol. 25, Iss. 6, 2011-06 ,pp. : 447-457

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of primary CNS lymphoma

By Park Deric Minwoo   Abrey Lauren E  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 1, 2002-01 ,pp. : 39-49

Informa Healthcare

Access to resources Recommend Favorite

Temozolomide plus whole-brain irradiation (WBI) is effective for patients with brain metastases from various solid tumours

By  

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Advanced-Stage Follicular Lymphoma in the Rituximab Era: When Should Patients Receive Anthracycline-Based Chemotherapy?

By Pettengell Ruth  

Drugs, Vol. 69, Iss. 13, 2009-09 ,pp. : 1727-1737

Adis International

Access to resources Recommend Favorite

Mycophenolate mofetil: Primary CNS lymphoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1137, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite